Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is EuroEyes International Eye Clinic PEG Ratio?
EuroEyes International Eye ClinicHKSE:01846 -1.82%81 PEG Ratio is 2.17 as of Aug. 18, 2026, which is 21600% above its 10-year median of 0.01. GuruFocus rates HKSE:01846 with a GF Score™ of 81/100 and a GF Value™ of HK$5.59 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 226 Healthcare Providers & Services companies, EuroEyes International Eye Clinic ranks worse than 67.7% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
HKSE:01846'
s PEG Ratio Range Over the Past 10 Years
Min: 0.01 Med: 0.01 Max: 2.45
Current: 2.17
During the past 10 years, EuroEyes International Eye Clinic's highest PEG Ratio was 2.45. The lowest was 0.01. And the median was 0.01.
HKSE:01846's PEG Ratio is ranked worse than 67.7% of 226
companies
in the Healthcare Providers & Services industry
Industry Median: 1.365
vs HKSE:01846: 2.17
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
EuroEyes International Eye Clinic (HKSE:01846) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
EuroEyes International Eye Clinic PEG Ratio Related Terms
EuroEyes International Eye Clinic PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, EuroEyes International Eye Clinic's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EuroEyes International Eye Clinic PEG Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EuroEyes International Eye Clinic's PEG Ratio distribution charts can be found below:
* The bar in red indicates where EuroEyes International Eye Clinic's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
EuroEyes International Eye Clinic (HKSE:01846) has a PEG Ratio of 2.17 as of Aug. 18, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on EuroEyes International Eye Clinic and its competitors. This is 21600% above median its historical median of 0.01. Over the past decade, EuroEyes International Eye Clinic's PEG Ratio has ranged from 0.01 to 2.45. According to the industry distribution chart, EuroEyes International Eye Clinic ranks #153 out of 226 companies in the Healthcare Providers & Services industry, placing it in the top 67.7%.
Is EuroEyes International Eye Clinic's PEG Ratio too high?
EuroEyes International Eye Clinic's current PEG Ratio of 2.17 is 21600% above median its 10-year median of 0.01. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 2.45. The Healthcare Providers & Services industry median PEG Ratio is 1.37. EuroEyes International Eye Clinic's value of 2.17 is 59% above this industry median. Based on the distribution chart, EuroEyes International Eye Clinic ranks #153 out of 226 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, EuroEyes International Eye Clinic has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EuroEyes International Eye Clinic's PEG Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, EuroEyes International Eye Clinic ranks #153 out of 226 companies for PEG Ratio. This places EuroEyes International Eye Clinic in the lower half of its industry. The industry median PEG Ratio is 1.37. EuroEyes International Eye Clinic's value of 2.17 is 59% above this benchmark. Historically, EuroEyes International Eye Clinic's own PEG Ratio has ranged from 0.01 to 2.45 over the past decade. While the company's 10-year median is 0.01 vs. the industry median of 1.37, EuroEyes International Eye Clinic has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Healthcare Providers & Services company?
The median PEG Ratio among Healthcare Providers & Services companies is 1.37, based on 226 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EuroEyes International Eye Clinic's current PEG Ratio of 2.17 is 59% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on EuroEyes International Eye Clinic and its competitors. For the Healthcare Providers & Services industry, the median PEG Ratio is 1.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EuroEyes International Eye Clinic's current PEG Ratio is 2.17, which is 21600% above median its own 10-year median of 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EuroEyes International Eye Clinic stock overvalued right now?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic (HKSE:01846) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$5.59, compared to a current price of HK$2.70 — trading 51.7% below its estimated fair value. The current PEG Ratio is 2.17, which is 21600% above median its 10-year median of 0.01 and 59% above the Healthcare Providers & Services industry median of 1.37. EuroEyes International Eye Clinic's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For EuroEyes International Eye Clinic (HKSE:01846), the current PEG Ratio is 2.17 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EuroEyes International Eye Clinic (HKSE:01846) Overvalued in 2026?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic stock appears to be undervalued.
The current stock price of HK$2.70 is trading 51.7% below its estimated GF Value™ of HK$5.59.
GuruFocus considers EuroEyes International Eye Clinic to be Significantly Undervalued.
Key valuation signals for HKSE:01846:
PEG Ratio: 2.17 (21600% above median its 10-year median of 0.01)
GF Value™: HK$5.59 vs. price of HK$2.70 (51.7% below fair value)
Industry Position: 59% above the Healthcare Providers & Services median (#153 of 226)
No single metric tells the full story. See the HKSE:01846 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EuroEyes International Eye Clinic Ltd is principally engaged in the provision of vision correction services in Germany, Denmark, the UK, the PRC including Hong Kong, and Switzerland. The Group is a high-end vision correction service provider in Germany, PRC, the UK, Denmark, and Switzerland. Its vision correction services include refractive laser surgery, phakic lens surgery (ICL), lens exchange surgery, and others including PRK/LASEK and ICRS implantation. Its revenue categories include provision of vision correction services generate maximum revenue, training services, sales of pharmaceutical products and others. The Group's five reportable segments are Germany generate maximum revenue, Denmark, UK, Chinese Mainland, and Switzerland.
81GF Score
Get the complete analysis for HKSE:01846
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01846 has been successfully added to your 
